First Horizon Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$94.2K Buy
936
+186
+25% +$14.2K ﹤0.01% 735
2025
Q1
$57.2K Buy
750
+40
+6% +$3.06K ﹤0.01% 874
2024
Q4
$49K Buy
710
+24
+3% +$1.73K ﹤0.01% 951
2024
Q3
$50.1K Buy
686
+55
+9% +$4.06K ﹤0.01% 987
2024
Q2
$42.3K Buy
631
+287
+83% +$11.1K ﹤0.01% 986
2024
Q1
$9.33K Hold
344
﹤0.01% 1610
2023
Q4
$10.7K Hold
344
﹤0.01% 1570
2023
Q3
$8.69K Buy
344
+18
+6% +$412 ﹤0.01% 1567
2023
Q2
$6.88K Hold
326
﹤0.01% 1688
2023
Q1
$5.56K Hold
326
﹤0.01% 1776
2022
Q4
$6.51K Buy
+326
New +$6.3K ﹤0.01% 1715

Other funds holding INSM

First Horizon Advisors's INSM Position: Q2 2025 in Review

First Horizon Advisors increased its Insmed (INSM) stake by 25% in Q2 2025, buying an estimated $14.2K and bringing the position to 936 shares worth $94.2K. The position accounts for ﹤0.01% of the portfolio, ranked #735.

First Horizon Advisors first reported a position in INSM in Q4 2022 and has held it in 11 quarters since. 516 funds tracked by Wall St. Rank hold INSM as of Q2 2025.

  • First Horizon Advisors held 936 shares of Insmed worth $94.2K as of Q2 2025.
  • First Horizon Advisors bought 186 Insmed shares in Q2 2025, an estimated $14.2K.
  • Insmed made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #735 holding.
  • First Horizon Advisors first reported a position in Insmed in Q4 2022 and has held it in 11 quarters since.
  • 516 funds tracked by Wall St. Rank held Insmed as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.